Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELICE-BD lurasidone adjunctive therapy study in euthymic bipolar disorder
jRCTs031180065Completed
- Sponsor
- University of British Columbia
- Start
- Jan 2019
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in bipolar disorder (BD) comparing Lurasidone adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoints: Change in composite cognitive score and Change in functioning by UPSA-B. Started Jan 2019; status: completed.
02
Drugs
lurasidone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on jRCTs031180065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180065.